<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">34916430</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>02</Month>
        <Day>04</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">1673-5374</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>17</Volume>
            <Issue>7</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jul</Month>
            </PubDate>
          </JournalIssue>
          <Title>Neural regeneration research</Title>
          <ISOAbbreviation>Neural Regen Res</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Neurotrophin receptοrs, gamma-secretase inhibitors, and neurodegeneration of basal forebrain cholinergic neurons.</ArticleTitle>
        <Pagination>
          <StartPage>1493</StartPage>
          <EndPage>1494</EndPage>
          <MedlinePgn>1493-1494</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.4103/1673-5374.330607</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Vilar</LastName>
            <ForeName>Marçal</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Instituto de Biomedicina de València del CSIC, València, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Neural Regen Res</MedlineTA>
        <NlmUniqueID>101316351</NlmUniqueID>
        <ISSNLinking>1673-5374</ISSNLinking>
      </MedlineJournalInfo>
      <CoiStatement>None</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>14</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34916430</ArticleId>
        <ArticleId IdType="pmc">PMC8771120</ArticleId>
        <ArticleId IdType="doi">10.4103/1673-5374.330607</ArticleId>
        <ArticleId IdType="pii">NeuralRegenRes_2022_17_7_1493_330607</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Acx H, Serneels L, Radaelli E, Muyldermans S, Vincke C, Pepermans E, Müller U, Chávez-Gutiérrez L, De Strooper B. Inactivation of γ-secretases leads to accumulation of substrates and non-Alzheimer neurodegeneration. EMBO Mol Med. 2017;9:1088–1099.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5538297</ArticleId>
            <ArticleId IdType="pubmed">28588032</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ancolio K, Marambaud P, Dauch P, Checler F. Alpha-secretase-derived product of beta-amyloid precursor protein is decreased by presenilin 1 mutations linked to familial Alzheimer's disease. J Neurochem. 1997;69:2494–2499.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9375682</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chávez-Gutiérrez L, Bammens L, Benilova I, Vandersteen A, Benurwar M, Borgers M, Lismont S, Zhou L, Van Cleynenbreugel S, Esselmann H, Wiltfang J, Serneels L, Karran E, Gijsen H, Schymkowitz J, Rousseau F, Broersen K, De Strooper B. The mechanism of γ-secretase dysfunction in familial Alzheimer disease. EMBO J. 2012;31:2261–2274.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3364747</ArticleId>
            <ArticleId IdType="pubmed">22505025</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Checler F, Afram E, Pardossi-Piquard R, Lauritzen I. Is γ-secretase a beneficial inactivating enzyme of the toxic APP C-terminal fragment C99? J Biol Chem. 2021;296:100489.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8027268</ArticleId>
            <ArticleId IdType="pubmed">33662398</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Díaz-Moreno M, Hortigüela R, Gonçalves A, García-Carpio I, Manich G, García-Bermúdez E, Moreno-Estellés M, Eguiluz C, Vilaplana J, Pelegrí C, Vilar M, Mira H. Aβ increases neural stem cell activity in senescence-accelerated SAMP8 mice. Neurobiol Aging. 2013;34:2623–2638.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23796660</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Franco ML, García-Carpio I, Comaposada-Baró R, Escribano-Saiz JJ, Chávez-Gutiérrez L, Vilar M. TrkA-mediated endocytosis of p75-CTF prevents cholinergic neuron death upon γ-secretase inhibition. Life Sci Alliance. 2021;4:e202000844.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7898468</ArticleId>
            <ArticleId IdType="pubmed">33536237</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ginsberg SD, Che S, Wuu J, Counts SE, Mufson EJ. Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease. J Neurochem. 2006;97:475–487.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16539663</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kraemer BR, Yoon SO, Carter BD. The biological functions and signaling mechanisms of the p75 neurotrophin receptor. Handb Exp Pharmacol. 2014;220:121–164.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24668472</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kuperstein I, Broersen K, Benilova I, Rozenski J, Jonckheere W, Debulpaep M, Vandersteen A, Segers-Nolten I, Van Der Werf K, Subramaniam V, Braeken D, Callewaert G, Bartic C, D’Hooge R, Martins IC, Rousseau F, Schymkowitz J, De Strooper B. Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio. EMBO J. 2010;29:3408–3420.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2957213</ArticleId>
            <ArticleId IdType="pubmed">20818335</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li T, Wen H, Brayton C, Das P, Smithson LA, Fauq A, Fan X, Crain BJ, Price DL, Golde TE, Eberhart CG, Wong PC. Epidermal growth factor receptor and notch pathways participate in the tumor suppressor function of gamma-secretase. J Biol Chem. 2007;282:32264–32273.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17827153</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Underwood CK, Reid K, May LM, Bartlett PF, Coulson EJ. Palmitoylation of the C-terminal fragment of p75(NTR) regulates death signaling and is required for subsequent cleavage by gamma-secretase. Mol Cell Neurosci. 2008;37:346–358.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18055214</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vicario A, Kisiswa L, Tann JY, Kelly CE, Ibáñez CF. Neuron-type-specific signaling by the p75NTR death receptor is regulated by differential proteolytic cleavage. J Cell Sci. 2015;128:1507–1517.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25720379</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
